The Sorry State of Indian Surrogates
By Gina Maranto, <i>Biopolitical Times</i> guest contributor
| 08. 06. 2013
The surrogacy industry in India is both booming and changing. A new 168-page report from the Centre for Social Research, a women’s advocacy group based in New Delhi, finds that the industry appears to be shifting from towns like Anand and Amritsar to the megacities Mumbai and New Delhi, which are more easily accessible to international travelers and have higher quality health care facilities. Surrogate Motherhood: Ethical or Commercial documents a range of disturbing conditions: Although the government has guidelines for assisted reproduction clinics, regulation continues to be spotty and current law affords scant protection to the poor, largely uneducated women who are being drafted to serve as incubators, or to the resulting children handed over to primarily foreign clients.
Foreign scholars and journalists have probed the Indian surrogacy business for some years. Within the country, groups like the Sama Resource Group for Women and Health have drawn attention to the broader practices of ART clinics, as in their 2008 publication Cheap and Best, which puts the industry in the context of global medical tourism and examines the...
Related Articles
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...